Neoadjuvant Chemo-Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis of neoadjuvant ICI-chemotherapy RCTs in patients with early-stage NSCLC, 3 cycles of neoadjuvant platinum-based ICI-chemotherapy were associated with a meaningful improvement in 2-year EFS and pCR.PMID:38625698 | DOI:10.1001/jamanetworkopen.2024.6837
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research